Ophirex, Inc.

First in Class: Begin treating any snakebite, any place, any time with Ophirex antidotes--Oral, IV and SC for human and veterinary use. A $30BB market.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Corte Madera, CA, US
  • Currency USD
  • Founded January 2015
  • Employees 2
  • Incorporation Type C-corp

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free